Markets

Sector Update: Healh Care Stocks Ending Mixed; Tekmira Pharma Begins Producing Eloba Drug Candidate

Top Healthcare Stocks

JNJ +1.35%

PFE +0.41%

ABT -1.65%

MRK +0.94%

AMGN -0.06%

Health care stocks were mixed heading into Wednesday's close with the NYSE Health Care Sector Index advancing about 0.2% while shares of health care companies in the S&P 500 were down more than 0.2% as a group.

In company news, Tekmira Pharmaceuticals ( TKMR ) was getting a late boost after the biotech company this afternoon said it has begun limited manufacturing of a new therapeutic specifically targeting the Ebola.

The company said small amounts of the so-called Guinea variant - the viral variant responsible for the current Ebola epidemic in western Africa - should be available in early December for potential use by various collaborators.

It also said the new drug application for the company's TKM-Ebola candidate remains on partial clinical hold while regulators consider dosing levels in healthy subjects. It expects those questions will be resolved before the end of 2014.

TKMR shares were up almost 9% at $19.55 apiece, bouncing back from a mid-day slide to $18.80 a share. The stock has traded within a 52-week range of $7.17 to $31.48 a share, jumping more than 112% over the past 12 months through Tuesday's close.

In other sector news,

(+) IBIO, Expands exclusive product collaboration with Novici Biotech to include IBIO's proprietary IBIO-CFB03 product for idiopathic pulmonary fibrosis, systemic sclerosis and other fibrotic diseases.

(-) BIIB, Confirms patient death from progressive multifocal leukoencephalopathy, a rare brain infection, after using its Tysabri multiple sclerosis drug, trumping better-than-expected Q3 earnings and revenue.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Commodities

Latest Markets Videos